Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raplixa versus TachoSil for surgical hemostasis during hepatic resection
2014-000816-32Phase 3Completed
- Sponsor
- ProFibrix
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tachosil in Not applicable (2 arms), sponsored by ProFibrix. Primary endpoint: Hemostasis at 3 minutes. Started May 2014; status: completed.
02
Drugs
tachosil
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2014-000816-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000816-32.